miRNA-21 also acts on ovarian cancer via the PI3K/AKT/mTOR pathway by suppressing PTEN, and is even activated by AKT in hypoxic conditions to induce survival [65,66]. The gene discussed is AKT1; the disease is ovarian carcinoma.